News for 'drug firms'

Ballooning condom prices bring in regulator, 2 tiers likely

Ballooning condom prices bring in regulator, 2 tiers likely

Rediff.com2 Mar 2017

The National Pharmaceutical Pricing Authority has decided to have one price for basic utility condoms and the other for pleasure condoms.

China grants conditional nod to homegrown COVID-19 vaccine

China grants conditional nod to homegrown COVID-19 vaccine

Rediff.com31 Dec 2020

The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.

Boxer Leon Spinks, who shocked Muhammad Ali, dies at 67

Boxer Leon Spinks, who shocked Muhammad Ali, dies at 67

Rediff.com7 Feb 2021

Spinks' aggressive style and superior stamina allowed him to outduel Ali in a 15-round split decision, becoming the first boxer to take the title from Ali in the ring.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

US regulator frowns on Sun-Ranbaxy deal

US regulator frowns on Sun-Ranbaxy deal

Rediff.com31 Jan 2015

The proposed merger would likely harm future competition

COVID-19 in India: Nobody is really in control

COVID-19 in India: Nobody is really in control

Rediff.com26 Jun 2020

When BJP leaders, including Mr Modi's number two, Amit Shah, use the pandemic to launch an assault on state governments run by opposition parties, or to topple them, they are exploiting a grave crisis in cynical political self-interest, notes Shekhar Gupta.

What India is doing to contain coronavirus outbreak

What India is doing to contain coronavirus outbreak

Rediff.com18 Mar 2020

As the Indian Army reported its first case of the infection with a 34-year-old soldier testing positive in Leh, the Army said it has taken a series of precautionary measures to prevent the spread of coronavirus among the forces such as checking flu symptoms among soldiers on their return from leave and cancelling non-essential travel, conferences and recruitment drives.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

Black money: What have you done so far, SC asks govt

Black money: What have you done so far, SC asks govt

Rediff.com27 Jan 2011

The Supreme Court on Thursday slammed the government again over the issue of illicit wealth parked in foreign banks, asking it to file a report on the action taken by it against people and firms that have stashed black money in tax havens abroad.

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.

'This is the worst crisis in our lifetime'

'This is the worst crisis in our lifetime'

Rediff.com9 Apr 2009

"The credit turmoil that the world is seeing now is clearly the worst in history," says Habil Khorakiwala, executive chairman, Wockhardt. He should know, as his company finds itself in trouble over a Rs 3,400 crore debt burden.

Managing Internet tech change wisely

Managing Internet tech change wisely

Rediff.com26 Mar 2021

Ajit Balakrishnan on learning from past technology revolutions.

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

Finally, Ranbaxy becomes part of Daiichi Sankyo

Finally, Ranbaxy becomes part of Daiichi Sankyo

Rediff.com21 Oct 2008

While 22 per cent of the promoters' stake in Ranbaxy was sold through an off-market transaction, the remaining came from a preferential share allotment. Daiichi Sankyo had earlier picked up more than 20 per cent of Ranbaxy's shares through an open offer. Ranbaxy Chairman and Managing Director Malvinder Mohan Singh said the remaining 12-13 per cent promoter shareholding will change hands in the coming weeks, thereby taking Daiichi's share in Ranbaxy to over 60 per cent.

Daiichi to take on Mylan, Teva

Daiichi to take on Mylan, Teva

Rediff.com12 Jun 2008

Daiichi-Sankyo's $5.3 billion acquisition of India's biggest drugmaker will help the Japanese company compete in the US markets with rivals such as Mylan and Israel-based Teva Pharmaceuticals and climb to become the world's 15th largest pharmaceutical company. Thus it is an important move on the part of an original drug research company to attach generic business portfolio," noted Ranjit Shahani, the vice-chairman and managing director of Novartis India.

Biocon launches pre-filled  syringes for cancer

Biocon launches pre-filled syringes for cancer

Rediff.com5 Jun 2008

The products, named as 'Erypro Safe' and 'Nufil Safe', have been launched in collaboration with California-based firm Safety Syringes, which makes syringes for vaccines and other medicines. While Erypro Safe is used in the treatment of chronic kidney disease, Nufil Safe is used for cancer treatment. With the new device, patients can be injected with the drug conveniently, without drawing the medicine into a syringe from a vial.

Dr Reddy's sells US facility to UAE-based Neopharma

Dr Reddy's sells US facility to UAE-based Neopharma

Rediff.com2 Oct 2018

The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin

Alkem fudged trial data: German regulator

Alkem fudged trial data: German regulator

Rediff.com16 Apr 2016

The European Medicines Agency's review is the second setback to Alkem Laboratories

Delhi HC sets aside government decision to cap condom prices

Delhi HC sets aside government decision to cap condom prices

Rediff.com11 Jul 2015

In a relief to pharma majors, the Delhi high court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the luxury variety.

Cornet charged with anti-doping violation

Cornet charged with anti-doping violation

Rediff.com25 Jan 2018

France's Alize Cornet has been charged by the Tennis Anti-Doping Programme (TADP) after allegedly missing three out-of-competition drug tests, governing body the ITF said on Thursday.

The mistakes Daiichi Sankyo made in the Ranbaxy deal

The mistakes Daiichi Sankyo made in the Ranbaxy deal

Rediff.com12 May 2016

The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.

Sun Pharma acquires US-based Pharmalucence

Sun Pharma acquires US-based Pharmalucence

Rediff.com16 Jul 2014

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

3 Ranbaxy units face ban if US charges are proved

3 Ranbaxy units face ban if US charges are proved

Rediff.com15 Jul 2008

Experts said it is the first time that an Indian pharmaceutical company has been charged with such serious offences, and that the firm may be prosecuted if the allegations are proved. Able Labs of the US, now a unit of Sun Pharma through an acquisition in 2005, had to face similar charges in 2004-2005.

Glenmark initiates studies to develop new molecule

Glenmark initiates studies to develop new molecule

Rediff.com4 Feb 2013

It can possibly be used to treat diseases like Arthritis and bowel disease.

Sensex rises snapping two-session losing streak; banks, auto gain

Sensex rises snapping two-session losing streak; banks, auto gain

Rediff.com26 Nov 2015

Sensex rises, snapping two-session losing streak; banks, auto gain.

How Allergan plans to boost Botox sales in Indian market

How Allergan plans to boost Botox sales in Indian market

Rediff.com15 Aug 2018

While the Botox segment is growing annually at around 20-25% in the country, Allergan India's aesthetics business is growing at 60%

Roche's patent pain to be Biocon's gain

Roche's patent pain to be Biocon's gain

Rediff.com19 Aug 2013

Indian firm to soon launch copycat of anti-breast-cancer drug.

Two Britons sentenced to life for murdering NRI

Two Britons sentenced to life for murdering NRI

Rediff.com15 May 2008

Balbir Matharu, 54, who hailed from Punjab, was killed after confronting the drug addict duo when he saw one of them smash the window of his white Mercedes van. Matharu was working at his family building firm in Stratford in east London when the incident occurred on January 12, 2006.He chased the thieves, who ran and jumped into a waiting Ford Mondeo and knocked him as he tried to stop their getaway."The crime is beneath contempt," Judge Moss told the brothers.

Sports Shorts: Tiger Woods set to return; Farah splits with coach

Sports Shorts: Tiger Woods set to return; Farah splits with coach

Rediff.com31 Oct 2017

A summary of sports events and sports persons, who made news on Tuesday

Mankind plans to open US plant, invest Rs 300 crore

Mankind plans to open US plant, invest Rs 300 crore

Rediff.com21 Jan 2016

Mankind has presence in Sri Lanka, Myanmar, Cambodia, Kenya, Uganda, Zambia and Tanzania.

Cipla gets relief in patent battle with Pfizer

Cipla gets relief in patent battle with Pfizer

Rediff.com12 Feb 2013

The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.

NRI's energy drink under scanner for 13 deaths in US

NRI's energy drink under scanner for 13 deaths in US

Rediff.com16 Nov 2012

A popular energy drink, produced by a company founded by an Indian-American billionaire, has come under the scanner in the United States after reports of 13 deaths possibly linked to the energy shots.

Was India underprepared for a lockdown?

Was India underprepared for a lockdown?

Rediff.com14 Apr 2020

India is going into the longest lockdown in the world, with the least amount of notice given to its people and the least preparation by its government.

To keep essentials flowing Centre widens grocery inclusions

To keep essentials flowing Centre widens grocery inclusions

Rediff.com4 Apr 2020

In the last one week several companies have had to face the hurdle of making a distinction between what's essential and what's not. To help them the government has now clarified that grocery would include hygiene products such as hand wash, soaps, disinfectants, body wash, shampoo, surface cleaners, detergents, tissue paper, toothpaste, oral care, sanitary pads, diapers, chargers and battery cells, etc.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

TCS wins BPO deal from Eli Lilly

TCS wins BPO deal from Eli Lilly

Rediff.com15 Nov 2006

India's largest IT services firm Tata Consultancy Services on Wednesday said it won a contract from Eli Lilly to provide various drug development services to the US pharma firm.

Sun-Ranbaxy merger clears last hurdle

Sun-Ranbaxy merger clears last hurdle

Rediff.com10 Mar 2015

On January 31, the US Federal Trade Commission cleared the merger.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Does Siddha medicine have a Covid cure?

Does Siddha medicine have a Covid cure?

Rediff.com8 Aug 2020

'Not one single, but multiple trials are there to quote. However, these will be published as scientific manuscripts.' 'This includes integrative as well as standalone approaches in Covid mitigation.'

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.